Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UMPIRE polypill versus usual care for secondary cardiovascular prevention
NL-OMON36717Phase 3Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin, simvastatin, lisinopril, atenolol and hydrochlorothiazide in cardiac morbidity, hypertension (HTN) and atherothrombosis (2 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Adherence to indicated medications, Change in blood pressure and 1 more. Started Aug 2010; status: active, not recruiting.
02
Drugs
aspirinsimvastatinlisinoprilatenololhydrochlorothiazide
03
Conditions
cardiac morbidityhypertension (HTN)atherothrombosis
Beyond the preview
Go deeper on NL-OMON36717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36717.